UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000031064
Receipt No. R000035417
Official scientific title of the study To investigate the effect of ripasudil hydrochloride hydrate eye drops for retinal vein occlusion(RVO)
Date of disclosure of the study information 2018/02/01
Last modified on 2018/01/30 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study To investigate the effect of ripasudil hydrochloride hydrate eye drops for retinal vein occlusion(RVO)
Title of the study (Brief title) The effect of ripasudil eye drops for RVO
Region
Japan

Condition
Condition Retinal vein occlusion
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Among patients with both retinal vein occlusion and glaucoma, those who do not achieve complete regression of macula edema with anti-VEGF drugs or who need frequent injection of anti-VEGF drugs are enrolled in this study. We consider if the patients achieve complete regression of macula edema or need less injection of anti-VEGF drugs using ripasudil hydrochloride hydrate eye drops which is one of the ROCK inhibitor.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The change in central retinal thickness measured by optical coherence tomography before and 12 after the treatment
Key secondary outcomes The frequency of intravitreal injection of anti-VEGF drugs

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Administration of ripasudil eye drops twice a day for 12 months.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients who have early glaucoma or ocular hypertension
Patients who do not have complete regression of macula edema with intravitreal injection of anti-VEGF drugs, or who need frequent injection of drugs to maintain the condition of complete disappearance of edema
Patients aged 20 years and older at the time of informed consent
Patients who gave written consent to study participation by free documentation and verbally enough explanation
Key exclusion criteria Patients with other ocular disorders
Patients with a bad control of intra ocular pressure
Others who are deemed unsuitable for inclusion in the study for any other reason based on the assessment by the investigators
Target sample size 10

Research contact person
Name of lead principal investigator Tsuyoshi Otsuji
Organization Kansai Medical University Medical Center
Division name Ophthalmology
Address 10-15 Fumizonocho Moriguchi, Osaka
TEL 06-6992-1001
Email otsuji@takii.kmu.ac.jp

Public contact
Name of contact person Tsuyoshi Otsuji
Organization Kansai Medical University Medical Center
Division name Ophthalmology
Address 10-15 Fumizonocho Moriguchi, Osaka
TEL 06-6992-1001
Homepage URL
Email otsuji@takii.kmu.ac.jp

Sponsor
Institute Kansai Medical University Medical Center
Institute
Department

Funding Source
Organization Self funding
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 02 Month 01 Day

Progress
Recruitment status Preinitiation
Date of protocol fixation
2017 Year 11 Month 20 Day
Anticipated trial start date
2018 Year 02 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2018 Year 01 Month 30 Day
Last modified on
2018 Year 01 Month 30 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035417